Penn Medicine Lancaster General Health — price list
← Hospital overviewVerified from Penn Medicine Lancaster General Health’s published price file
Includes cash prices, list prices, insurance-negotiated rates. Open any row for plan-level negotiated rates. This is public hospital price transparency data, not a guaranteed estimate of your bill.
How to read these columns
- List
- The hospital’s full undiscounted (gross) charge — rarely what anyone actually pays.
- Cash
- The discounted self-pay price for paying directly, without insurance.
- Negotiated
- Rates agreed with insurers; open a row for plan-level detail. Your share depends on your benefits.
These are the hospital’s published reference prices, not a personalized estimate of your bill.
95 prices shown.
| Service | Code | List price | Cash price | Negotiated range | Allowed (median) | |
|---|---|---|---|---|---|---|
| ABATACEPT 250 MG IV SOLR Inpatient | J0129 HCPCS | $4,483 | $4,483 | $1,278 – $4,483 | — | |
| ABATACEPT 250 MG IV SOLR Outpatient | J0129 HCPCS | $4,483 | $4,483 | $44.11 – $13,500 | — | |
| AZTREONAM 1 G IJ SOLR Inpatient | J0457 HCPCS | $93.10 | $93.10 | $26.53 – $93.10 | — | |
| AZTREONAM 1 G IJ SOLR Outpatient | J0457 HCPCS | $93.10 | $93.10 | $2.23 – $13,500 | — | |
| AZTREONAM 2 G IJ SOLR Inpatient | J0457 HCPCS | $175 | $175 | $49.95 – $175 | — | |
| AZTREONAM 2 G IJ SOLR Outpatient | J0457 HCPCS | $175 | $175 | $2.23 – $13,500 | — | |
| BELATACEPT 250 MG IV SOLR Inpatient | J0485 HCPCS | $2,775 | $2,775 | $791 – $2,775 | — | |
| BELATACEPT 250 MG IV SOLR Outpatient | J0485 HCPCS | $2,775 | $2,775 | $3.89 – $13,500 | — | |
| BEZLOTOXUMAB 1000 MG/40ML IV SOLN Inpatient | J0565 HCPCS | $11,411 | $11,411 | $3,252 – $11,411 | — | |
| BEZLOTOXUMAB 1000 MG/40ML IV SOLN Outpatient | J0565 HCPCS | $11,411 | $11,411 | $39.83 – $13,500 | — | |
| CAPECITABINE 150 MG ORAL TABS Inpatient | J8522 HCPCS | $105 | $105 | $29.88 – $105 | — | |
| CAPECITABINE 150 MG ORAL TABS Outpatient | J8522 HCPCS | $105 | $105 | $0.03 – $13,500 | — | |
| CAPECITABINE 500 MG ORAL TABS Inpatient | J8522 HCPCS | $194 | $194 | $55.35 – $194 | — | |
| CAPECITABINE 500 MG ORAL TABS Outpatient | J8522 HCPCS | $194 | $194 | $0.03 – $13,500 | — | |
| CASPOFUNGIN ACETATE 50 MG IV SOLR Inpatient | J0637 HCPCS | $944 | $944 | $269 – $944 | — | |
| CASPOFUNGIN ACETATE 50 MG IV SOLR Outpatient | J0637 HCPCS | $944 | $944 | $2.27 – $13,500 | — | |
| CASPOFUNGIN ACETATE 70 MG IV SOLR Inpatient | J0637 HCPCS | $984 | $984 | $280 – $984 | — | |
| CASPOFUNGIN ACETATE 70 MG IV SOLR Outpatient | J0637 HCPCS | $984 | $984 | $2.27 – $13,500 | — | |
| DONANEMAB-AZBT 350 MG/20ML IV SOLN Inpatient | J0175 HCPCS | $2,147 | $2,147 | $612 – $2,147 | — | |
| DONANEMAB-AZBT 350 MG/20ML IV SOLN Outpatient | J0175 HCPCS | $2,147 | $2,147 | $4.13 – $13,500 | — | |
| ELOTUZUMAB 300 MG IV SOLR Inpatient | J9176 HCPCS | $6,500 | $6,500 | $1,852 – $6,500 | — | |
| ELOTUZUMAB 300 MG IV SOLR Outpatient | J9176 HCPCS | $6,500 | $6,500 | $7.88 – $13,500 | — | |
| ELOTUZUMAB 400 MG IV SOLR Inpatient | J9176 HCPCS | $9,169 | $9,169 | $2,613 – $9,169 | — | |
| ELOTUZUMAB 400 MG IV SOLR Outpatient | J9176 HCPCS | $9,169 | $9,169 | $7.88 – $13,500 | — | |
| ERTAPENEM SODIUM 1 G IJ SOLR Inpatient | J1335 HCPCS | $374 | $374 | $107 – $374 | — | |
| ERTAPENEM SODIUM 1 G IJ SOLR Outpatient | J1335 HCPCS | $374 | $374 | $9.02 – $13,500 | — | |
| GEMTUZUMAB OZOGAMICIN 4.5 MG IV SOLR Inpatient | J9203 HCPCS | $25,936 | $25,936 | $7,392 – $25,936 | — | |
| GEMTUZUMAB OZOGAMICIN 4.5 MG IV SOLR Outpatient | J9203 HCPCS | $25,936 | $25,936 | $237 – $26,148 | — | |
| HYDROCORTISONE SOD SUC (PF) 100 MG IJ SOLR Inpatient | J1720 HCPCS | $73.60 | $73.60 | $20.98 – $73.60 | — | |
| HYDROCORTISONE SOD SUC (PF) 100 MG IJ SOLR Outpatient | J1720 HCPCS | $73.60 | $73.60 | $13.98 – $13,500 | — |